Tesamorelin (Egrifta) is a synthetic analogue of growth hormone-releasing hormone (GHRH) approved for research into GH secretion and metabolic endpoints. It stimulates pituitary GH release via the GHRH receptor and is widely used in preclinical models of lipodystrophy and body composition. Apex-grade lyophilised vials at ≥99% HPLC purity with full COA.
Add 2 mL bacteriostatic water for 5,000 mcg/mL (5 mg/mL).
Use our peptide reconstitution calculator →
Store lyophilised at −20 °C. Reconstituted: 4 °C, use within 28 days.
Every NewChem batch of Tesamorelin is independently tested prior to dispatch. Your COA documents HPLC purity (≥99%), identity confirmation via mass spectrometry, endotoxin screening, and a unique batch ID for full traceability. Sample COAs are available on request before purchase.
For a detailed step-by-step reconstitution guide for Tesamorelin, including BAC water measurements, syringe unit conversions, and storage protocols, see our dedicated guide:
